{"id":848,"date":"2025-08-28T13:49:52","date_gmt":"2025-08-28T11:49:52","guid":{"rendered":"https:\/\/www.genoscreen.fr\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/"},"modified":"2025-08-28T13:49:52","modified_gmt":"2025-08-28T11:49:52","slug":"genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant","status":"publish","type":"post","link":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/","title":{"rendered":"GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux"},"content":{"rendered":"<p>GenoScreen annonce le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, d\u00e9velopp\u00e9 en collaboration avec Clear Labs.<\/p>\n<p><!--more--><\/p>\n<p>Cette solution de nouvelle g\u00e9n\u00e9ration automatise enti\u00e8rement le test <a href=\"https:\/\/www.deeplex.com\/deeplex-myc-tb-tuberculosis-drug-resistance-diagnostic-kit\/\">Deeplex\u00ae Myc-TB<\/a> largement adopt\u00e9, permettant une d\u00e9tection rapide et compl\u00e8te des mutations de r\u00e9sistance aux m\u00e9dicaments et le g\u00e9notypage du complexe Mycobacterium tuberculosis (MTBC), ainsi qu&rsquo;une identification \u00e9tendue des mycobact\u00e9ries non tuberculeuses (MNT). Le produit est d\u00e9sormais disponible \u00e0 des fins de recherche uniquement (RUO).<\/p>\n<p>&nbsp;<\/p>\n<h2>Communiqu\u00e9 de presse<\/h2>\n<p><strong>GenoScreen and Clear Labs Announce the Launch of <a href=\"https:\/\/www.clearlabs.com\/cleardx\/#application-targeted-16s-and-its-sequencing-of-pathogens-from-human-and-other-biological-specimens\">Clear Dx\u2122<\/a> <a href=\"https:\/\/www.deeplex.com\/deeplex-myc-tb-tuberculosis-drug-resistance-diagnostic-kit\/\">Deeplex\u00ae Myc-TB<\/a>, an Automated Genomic Solution for Mycobacterium Characterization and TB Drug Resistance Detection<\/strong><\/p>\n<p><strong>Lille, France \u2013 August 26, 2025<\/strong> \u2013 GenoScreen, a biotechnology company pioneering advanced sequencing-based diagnostics, announces the launch of Clear Dx\u2122 Deeplex\u00ae Myc-TB, developed in collaboration with Clear Labs. This next-generation solution fully automates the widely adopted Deeplex\u00ae Myc-TB assay, enabling rapid and comprehensive detection of drug resistance mutations and genotyping of <em>Mycobacterium tuberculosis<\/em> complex (MTBC), and broad identification of non-tuberculous mycobacteria (NTM). The product is now available for Research Use Only (RUO).<\/p>\n<p>Tuberculosis (TB) remains a leading infectious killer worldwide, estimated to cause 10 million new cases and 1.5 million deaths each year by the World Health Organization. The rise of multidrug-resistant TB (MDR-TB) poses an urgent global health threat, while NTMs are emerging as increasingly significant pathogens linked to pulmonary and other forms of infections. These challenges highlight the critical need for accurate, rapid, and scalable molecular solutions.<\/p>\n<p><strong>Addressing Global Health Challenges with Precision Genomics<\/strong><\/p>\n<p>Conventional TB diagnostics including culture-based drug susceptibility testing are laborious and slow\u2014often requiring weeks for results. Building on GenoScreen\u2019s expertise in targeted next-generation sequencing (tNGS), the Deeplex\u00ae Myc-TB assay has already been recognized internationally as a game changer tool for rapid and extensive drug resistance profiling, directly from clinical specimens. By integrating Deeplex\u00ae Myc-TB onto the Clear Dx\u2122 automated platform, GenoScreen and Clear Labs are making next-day genomic insights accessible with minimal hands-on time, reducing barriers for research and clinical laboratories worldwide.<\/p>\n<p><strong>Key features of Clear Dx\u2122 Deeplex\u00ae Myc-TB include:<\/strong><\/p>\n<ul>\n<li>Fully automated sequencing workflow: delivering sample-to-result insights with minimal manual intervention.<\/li>\n<li>Comprehensive identification: accurate detection of both MTBC and NTM species directly from clinical DNA.<\/li>\n<li>Faster turnaround: results available within 24 hours, compared to weeks with culture-based methods.<\/li>\n<li>Strain genotype and drug resistance mutation detection: robust genomic insights supporting surveillance of resistant TB strains.<\/li>\n<li>Scalable and compatible: designed for high-throughput research environments and integrated with Clear Dx\u2122 workflows.<\/li>\n<\/ul>\n<p><strong>A strategic collaboration for a greater impact<\/strong><\/p>\n<p><em>\u00ab\u00a0<\/em>We are excited about our partnership with Clear Labs to commercialize the Clear Dx\u2122 Deeplex\u00ae Myc-TB\u201d <em>&nbsp;<\/em>said Andr\u00e9 Tordeux, CEO of GenoScreen. <em>\u00ab\u00a0This collaboration merges our advanced TB drug resistance detection technology with Clear Labs&rsquo; automated platform, providing the healthcare and scientific community with a seamless, efficient solution for mycobacterial identification and profiling of drug resistance mutations. Together, we&rsquo;re advancing TB research and offering labs the tools they need to better understand and tackle this critical global health challenge.\u00a0\u00bb<\/em><\/p>\n<p><em>\u00ab\u00a0We are excited to bring Clear Dx\u2122 Deeplex<sup>\u00ae<\/sup> Myc-TB to market, offering an efficient, automated solution built on an established, well-regarded assay, with the goal of accelerating the fight against TB,\u00a0\u00bb <\/em>said Sasan Amini, CEO at Clear Labs.<em> \u00ab\u00a0This product not only enhances lab operations by improving efficiency and accuracy but also addresses key gaps in rapid Mycobacterium characterization. We&rsquo;re confident it will be a valuable tool for the clinical and scientific community.\u00a0\u00bb<\/em><\/p>\n<p><strong>About GenoScreen<\/strong><\/p>\n<p>GenoScreen is a biotechnology company based in Lille, France. The company develops NGS-based solutions for infectious disease research and diagnostics. With a particular focus on tuberculosis and antimicrobial resistance, the company&rsquo;s innovations include the Deeplex\u00ae range of products, which enables precise, rapid and extensive sequencing-based microbial characterisation. The company collaborates with leading public health institutions, clinical laboratories and research organisations around the world to address today&rsquo;s global health challenges.<\/p>\n<p><strong>About Clear Labs<\/strong><\/p>\n<p>Clear Labs is democratizing genomics with the fully automated, next-generation sequencing (NGS) platform for precision medicine and applied markets. Powered by its best-in-class technology that delivers unmatched accuracy and efficiency through sample-to-answer automation, Clear Labs&rsquo; turnkey solutions are built to meet the complex and evolving needs of clinical, public health, and applied markets, by enabling them to perform advanced genomics in-house in their own labs. Clear Labs simplifies workflows to improve the speed, reliability, and cost of sequencing for faster decision-making, reduced operational costs, and ultimately, better health outcomes for all.<\/p>\n<p>For more information on GenoScreen and Deeplex\u00ae Myc-TB, visit <strong>www.genoscreen.fr<\/strong><\/p>\n<p><strong>Media:<\/strong><\/p>\n<p>GenoScreen, +33(0)62 263&nbsp;777, <a href=\"mailto:contact@genoscreen.fr\"><\/a><a href=\"mailto:contact@genoscreen.fr\">contact@genoscreen.fr<\/a>&nbsp;&nbsp;<\/p>\n<p>SOURCE GenoScreen<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GenoScreen annonce le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, d\u00e9velopp\u00e9 en collaboration avec Clear Labs.<\/p>\n","protected":false},"author":1,"featured_media":1381,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-848","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux - GenoScreen<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux - GenoScreen\" \/>\n<meta property=\"og:description\" content=\"GenoScreen annonce le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, d\u00e9velopp\u00e9 en collaboration avec Clear Labs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/\" \/>\n<meta property=\"og:site_name\" content=\"GenoScreen\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T11:49:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.genoscreen.fr\/wp-content\/uploads\/Communique_de_presse_Clear_Dx_miniature_2-scaled.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Simon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@genoscreen\" \/>\n<meta name=\"twitter:site\" content=\"@genoscreen\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/\"},\"author\":{\"name\":\"Simon\",\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/#\\\/schema\\\/person\\\/16f77d942ec357acc1c3aa8c53b1e71c\"},\"headline\":\"GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux\",\"datePublished\":\"2025-08-28T11:49:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/\"},\"wordCount\":795,\"publisher\":{\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.genoscreen.fr\\\/wp-content\\\/uploads\\\/Communique_de_presse_Clear_Dx_miniature_2-scaled.png\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/\",\"url\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/\",\"name\":\"GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux - GenoScreen\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.genoscreen.fr\\\/wp-content\\\/uploads\\\/Communique_de_presse_Clear_Dx_miniature_2-scaled.png\",\"datePublished\":\"2025-08-28T11:49:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.genoscreen.fr\\\/wp-content\\\/uploads\\\/Communique_de_presse_Clear_Dx_miniature_2-scaled.png\",\"contentUrl\":\"https:\\\/\\\/www.genoscreen.fr\\\/wp-content\\\/uploads\\\/Communique_de_presse_Clear_Dx_miniature_2-scaled.png\",\"width\":2560,\"height\":960},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/actualites\\\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/\",\"name\":\"GenoScreen\",\"description\":\"Sp\u00e9cialiste de la g\u00e9nomique et de la bioinformatique depuis 2001\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/#organization\",\"name\":\"GenoScreen\",\"url\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.genoscreen.fr\\\/wp-content\\\/uploads\\\/logo-genoscreen-1.svg\",\"contentUrl\":\"https:\\\/\\\/www.genoscreen.fr\\\/wp-content\\\/uploads\\\/logo-genoscreen-1.svg\",\"width\":267,\"height\":91,\"caption\":\"GenoScreen\"},\"image\":{\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/genoscreen\",\"https:\\\/\\\/fr.linkedin.com\\\/company\\\/genoscreen\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/#\\\/schema\\\/person\\\/16f77d942ec357acc1c3aa8c53b1e71c\",\"name\":\"Simon\",\"sameAs\":[\"https:\\\/\\\/www.genoscreen.fr\"],\"url\":\"https:\\\/\\\/www.genoscreen.fr\\\/fr\\\/author\\\/simon\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux - GenoScreen","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/","og_locale":"fr_FR","og_type":"article","og_title":"GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux - GenoScreen","og_description":"GenoScreen annonce le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, d\u00e9velopp\u00e9 en collaboration avec Clear Labs.","og_url":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/","og_site_name":"GenoScreen","article_published_time":"2025-08-28T11:49:52+00:00","og_image":[{"width":2560,"height":960,"url":"https:\/\/www.genoscreen.fr\/wp-content\/uploads\/Communique_de_presse_Clear_Dx_miniature_2-scaled.png","type":"image\/png"}],"author":"Simon","twitter_card":"summary_large_image","twitter_creator":"@genoscreen","twitter_site":"@genoscreen","twitter_misc":{"\u00c9crit par":"Simon","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/#article","isPartOf":{"@id":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/"},"author":{"name":"Simon","@id":"https:\/\/www.genoscreen.fr\/fr\/#\/schema\/person\/16f77d942ec357acc1c3aa8c53b1e71c"},"headline":"GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux","datePublished":"2025-08-28T11:49:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/"},"wordCount":795,"publisher":{"@id":"https:\/\/www.genoscreen.fr\/fr\/#organization"},"image":{"@id":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.genoscreen.fr\/wp-content\/uploads\/Communique_de_presse_Clear_Dx_miniature_2-scaled.png","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/","url":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/","name":"GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux - GenoScreen","isPartOf":{"@id":"https:\/\/www.genoscreen.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/#primaryimage"},"image":{"@id":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.genoscreen.fr\/wp-content\/uploads\/Communique_de_presse_Clear_Dx_miniature_2-scaled.png","datePublished":"2025-08-28T11:49:52+00:00","breadcrumb":{"@id":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/#primaryimage","url":"https:\/\/www.genoscreen.fr\/wp-content\/uploads\/Communique_de_presse_Clear_Dx_miniature_2-scaled.png","contentUrl":"https:\/\/www.genoscreen.fr\/wp-content\/uploads\/Communique_de_presse_Clear_Dx_miniature_2-scaled.png","width":2560,"height":960},{"@type":"BreadcrumbList","@id":"https:\/\/www.genoscreen.fr\/fr\/actualites\/genoscreen-et-clear-labs-annoncent-le-lancement-de-clear-dx-deeplex-myc-tb-solution-genomique-automatisee-pour-la-caracterisation-des-mycobacteries-et-la-detection-de-la-resistance-aux-medicaments-ant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.genoscreen.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"GenoScreen et Clear Labs annoncent le lancement de Clear Dx\u2122 Deeplex\u00ae Myc-TB, solution g\u00e9nomique automatis\u00e9e pour la caract\u00e9risation des mycobact\u00e9ries et la d\u00e9tection de la r\u00e9sistance aux m\u00e9dicaments antituberculeux"}]},{"@type":"WebSite","@id":"https:\/\/www.genoscreen.fr\/fr\/#website","url":"https:\/\/www.genoscreen.fr\/fr\/","name":"GenoScreen","description":"Sp\u00e9cialiste de la g\u00e9nomique et de la bioinformatique depuis 2001","publisher":{"@id":"https:\/\/www.genoscreen.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.genoscreen.fr\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.genoscreen.fr\/fr\/#organization","name":"GenoScreen","url":"https:\/\/www.genoscreen.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.genoscreen.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.genoscreen.fr\/wp-content\/uploads\/logo-genoscreen-1.svg","contentUrl":"https:\/\/www.genoscreen.fr\/wp-content\/uploads\/logo-genoscreen-1.svg","width":267,"height":91,"caption":"GenoScreen"},"image":{"@id":"https:\/\/www.genoscreen.fr\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/genoscreen","https:\/\/fr.linkedin.com\/company\/genoscreen"]},{"@type":"Person","@id":"https:\/\/www.genoscreen.fr\/fr\/#\/schema\/person\/16f77d942ec357acc1c3aa8c53b1e71c","name":"Simon","sameAs":["https:\/\/www.genoscreen.fr"],"url":"https:\/\/www.genoscreen.fr\/fr\/author\/simon\/"}]}},"_links":{"self":[{"href":"https:\/\/www.genoscreen.fr\/fr\/wp-json\/wp\/v2\/posts\/848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.genoscreen.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.genoscreen.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.genoscreen.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.genoscreen.fr\/fr\/wp-json\/wp\/v2\/comments?post=848"}],"version-history":[{"count":0,"href":"https:\/\/www.genoscreen.fr\/fr\/wp-json\/wp\/v2\/posts\/848\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.genoscreen.fr\/fr\/wp-json\/wp\/v2\/media\/1381"}],"wp:attachment":[{"href":"https:\/\/www.genoscreen.fr\/fr\/wp-json\/wp\/v2\/media?parent=848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.genoscreen.fr\/fr\/wp-json\/wp\/v2\/categories?post=848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.genoscreen.fr\/fr\/wp-json\/wp\/v2\/tags?post=848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}